Siemens to Replace Healthineers CFO in Preparation for Listing Post author:Sam Post published:November 8, 2017 Post category:BioPharma The public listing that is expected to value the business at around $46 billion. Source: BioSpace You Might Also Like Novartis Showcases 4 Potential Blockbusters in Its Late-Stage Pipeline November 13, 2017 2 Biotechs Insiders Just Bought $70 Million Worth of Stock In June 7, 2017 Why Bluebird Bio Investors Aren't Singing the Blues December 12, 2017
